Sodium (2R,5S,13aR)-7,9-dioxo-10-((2,4,6-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13a-octahydro-2,5-methanopyrido[1,2:4,5]pyrazino[2,1-b][1,3]oxazepin-8-olate | Patent Number 10385067

US 10385067 B2
Application Number15624166
Publication NumberUS 20180065986 A1
Pendency2 years, 2 months, 6 days
Filled DateJun 15, 2017
Priority DateJun 20, 2014
Publication DateMar 8, 2018
Expiration DateJun 19, 2034
Inventor/ApplicantsIRENE CHEN
Ernest A. Carra
Vahid Zia
VAHID ZIA
ERNEST A. CARRA
Irene Chen
ExaminesHABTE, KAHSAY
Art Unit1624
Technology Center1600
Assignments
Gilead Sciences
Current
Gilead Sciences
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.